IDR 270.0
(0.74%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 1014.12 Billion IDR | -13.21% |
2022 | 1168.47 Billion IDR | 11.13% |
2021 | 1051.44 Billion IDR | 7.23% |
2020 | 980.55 Billion IDR | -11.3% |
2019 | 1105.42 Billion IDR | 8.06% |
2018 | 1022.96 Billion IDR | 2.08% |
2017 | 1002.12 Billion IDR | 22.79% |
2016 | 816.13 Billion IDR | 18.07% |
2015 | 691.24 Billion IDR | 19.56% |
2014 | 578.13 Billion IDR | 10.84% |
2013 | 521.61 Billion IDR | -1.54% |
2012 | 529.75 Billion IDR | 12.55% |
2011 | 470.66 Billion IDR | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q2 | 196.77 Billion IDR | 15.04% |
2024 Q3 | 204.36 Billion IDR | 3.86% |
2024 Q1 | 171.04 Billion IDR | -26.97% |
2023 Q3 | 224.99 Billion IDR | -23.45% |
2023 Q2 | 293.94 Billion IDR | 12.63% |
2023 Q1 | 260.97 Billion IDR | -10.64% |
2023 Q4 | 234.21 Billion IDR | 4.1% |
2023 FY | 1014.12 Billion IDR | -13.21% |
2022 FY | 1168.47 Billion IDR | 11.13% |
2022 Q3 | 310.92 Billion IDR | 4.96% |
2022 Q2 | 296.24 Billion IDR | 10.02% |
2022 Q1 | 269.25 Billion IDR | -5.28% |
2022 Q4 | 292.04 Billion IDR | -6.07% |
2021 Q1 | 225.29 Billion IDR | -19.62% |
2021 FY | 1051.44 Billion IDR | 7.23% |
2021 Q4 | 284.26 Billion IDR | -5.54% |
2021 Q3 | 300.93 Billion IDR | 24.9% |
2021 Q2 | 240.94 Billion IDR | 6.95% |
2020 Q4 | 280.28 Billion IDR | 13.77% |
2020 FY | 980.55 Billion IDR | -11.3% |
2020 Q1 | 229.36 Billion IDR | -26.83% |
2020 Q2 | 224.55 Billion IDR | -2.1% |
2020 Q3 | 246.34 Billion IDR | 9.7% |
2019 Q3 | 239.82 Billion IDR | -35.92% |
2019 Q4 | 313.48 Billion IDR | 30.71% |
2019 FY | 1105.42 Billion IDR | 8.06% |
2019 Q2 | 374.26 Billion IDR | 110.44% |
2019 Q1 | 177.84 Billion IDR | -45.41% |
2018 Q4 | 325.8 Billion IDR | 12.43% |
2018 Q1 | 140.03 Billion IDR | -61.26% |
2018 Q2 | 267.33 Billion IDR | 90.91% |
2018 FY | 1022.96 Billion IDR | 2.08% |
2018 Q3 | 289.79 Billion IDR | 8.4% |
2017 Q4 | 361.5 Billion IDR | 0.0% |
2017 FY | 1002.12 Billion IDR | 22.79% |
2016 FY | 816.13 Billion IDR | 18.07% |
2015 FY | 691.24 Billion IDR | 19.56% |
2014 FY | 578.13 Billion IDR | 10.84% |
2013 FY | 521.61 Billion IDR | -1.54% |
2012 FY | 529.75 Billion IDR | 12.55% |
2011 FY | 470.66 Billion IDR | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
PT Darya-Varia Laboratoria Tbk | 1890.88 Billion IDR | 46.368% |
PT Merck Tbk | 961.43 Billion IDR | -5.481% |
PT Pyridam Farma Tbk | 702.06 Billion IDR | -44.449% |
PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3565.93 Billion IDR | 71.561% |
PT Tempo Scan Pacific Tbk | 13119.78 Billion IDR | 92.27% |